Abstract:Abstract MicroRNAs (miRs) have been repeatedly linked to tumorigenesis and tumor progression, suggesting their potential value as biomarkers and targets for therapeutic intervention. Recent evidence suggests that mRNAs compete for binding and regulation by a finite pool of miRs, thus regulating each other as competitive endogenous RNAs (ceRNAs). The extent of this new regulatory layer and its potential to alter the expression of cancer genes has been shown in several tumor types, but the actual impact of ceRNA interactions on disease remains unclear. In this study, using TCGA (The Cancer Genome Atlas) tumor datasets, we provide evidence that ceRNA play an important role in tumor etiology. Leveraging millions of shRNA-mediated perturbations from LINCS (Library of Integrated Network-based Cellular Signatures), we extensively validated ceRNA interactions in breast and prostate cancer. Moreover, we identified over 160,000 ceRNA interactions that are conserved across tumor types despite being implemented by miR programs with tumor type-specific expression. We present evidence that these ultraconserved interactions are mechanistically responsible for the dysregulation of the majority of oncogenes and tumor suppressors through TCGA-profiled genomic alteration of their cognate ceRNA regulators. Using targeted biochemical validation in cell lines, we verified the potential of ceRNA regulators to target ESR1, an established oncogene and drug target in breast cancer, and APC, an established tumor suppressor in colon adenocarcinoma. Our analysis suggests that ceRNA interactions are implemented through competition for multiple miRNAs, rendering them virtually independent of single miRNA kinetics and availability, and more likely to be conserved across contexts. Using TCGA samples, we demonstrated that conserved ceRNA interactions enable systematic identification of genomic alterations that contribute to aberrant expression of hundreds of cancer genes in each of eight distinct tumor contexts. We submit this network as a resource for analyzing ceRNA regulation in datasets where reverse engineering context-specific networks is infeasible due to low sample number or lack of miRNA expression profiles. Citation Format: Hua-Sheng Chiu, Xuerui Yang, María Rodríguez Martínez, Archana Iyer, Pavel Sumazin, Andrea Califano. Highly conserved ceRNA regulatory interactions cooperate with genomic variability to modulate drivers of tumorigenesis. [abstract]. In: Proceedings of the 104th Annual Meeting of the American Association for Cancer Research; 2013 Apr 6-10; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2013;73(8 Suppl):Abstract nr 5231. doi:10.1158/1538-7445.AM2013-5231

Transcribed Ultraconserved Region in Human Cancers.

Abstract 3681: Transcribed ultraconserved regions are associated with survival in multiple tumor types

Ultraconserved Regions Encoding Ncrnas Are Altered in Human Leukemias and Carcinomas

A transcribed ultraconserved noncoding RNA, uc.285+, promotes colorectal cancer proliferation through dual targeting of CDC42 by directly binding mRNA and protein

Genome-wide Analysis of Long Non-Coding RNA Expression and Function in Colorectal Cancer

Transcriptome Sequencing of Hepatocellular Carcinoma Uncovers Multiple Types of Dysregulated Ncrnas

Abstract 456: A first comprehensive analysis of transcribed ultra conserved regions uncovers important regulatory functions of novel non-coding transcripts in gliomas

A comprehensive analysis of Transcribed Ultra Conserved Regions uncovers important regulatory functions of novel non-coding transcripts in gliomas

Global Identification and Characterization of Trna-Derived RNA Fragment Landscapes Across Human Cancers

TUCR.454 Inhabits Metastasis in Lung Cancer Cells.

Systematic Analysis Reveals Long Noncoding RNAs Regulating Neighboring Transcription Factors in Human Cancers.

Oncotrf: An Online Resource For Exploration Of Trna-Derived Fragments In Human Cancers

A transcriptome anatomy of human colorectal cancers

Noncoding RNAs: Different Roles in Tumorigenesis

CADTAD: CAncer Driver Topologically Associated Domains identify oncogenic and tumor suppressive lncRNAs

Comprehensive characterization genetic regulation and chromatin landscape of enhancer-associated long non-coding RNAs and their implication in human cancer

The common region of lncRNAs <i>UCA1</i> and <i>UCA1</i> contributes to the bladder cancer tumorigenesis

Pan-cancer Investigation of C-to-U Editing Reveals Its Important Role in Cancer Development and New Targets for Cancer Treatment

Abstract 5231: Highly Conserved Cerna Regulatory Interactions Cooperate with Genomic Variability to Modulate Drivers of Tumorigenesis.

Systematic Study of Human Long Intergenic Non-Coding RNAs and Their Impact on Cancer

Cis- and Trans-Acting Expression Quantitative Trait Loci of Long Non-Coding RNA in 2,549 Cancers With Potential Clinical and Therapeutic Implications